While processors of cannabis products must adhere to Good Production Practices unique to Canada, manufacturers of cannabis drugs must adhere to higher standards.
The globally recognized Good Manufacturing Practices (GMP) is necessary for any facility looking to create a cannabis drug. All materials including other Active Pharmaceuticals must be sourced from a lab that is GMP certified. Further, GACP (Good Agricultural Collection Practices) will apply to cannabis harvested for use as an API. Click here for our GMP Online Training.
You must have a valid Drug Establishment License (DEL) to qualify to apply for a Cannabis Drug License (CDL). You will be asked to provide details of your DEL site at your time of application for a CDL. A DEL allows the licensee to legally engage in any authorized activities and indicates (GMP) compliance.
In order to make valid medical claims about a cannabis product, you will need to obtain a Drug Identification Number (DIN) for that product. To obtain a DIN#, you must conduct a thorough clinical trial(s) and provide evidence of the claims to Health Canada.